Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Summer B Dewdney

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Gynecologic Oncology|October 13, 2018
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group studyBradley J Monk, James T Kauderer, Katherine M Moxley, et al.
Gynecologic Oncology|September 14, 2025
Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.SNancy Zhou, Anna L Beavis, Lilie L Lin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 17, 2012
Uterine serous carcinoma: increased familial risk for lynch-associated malignanciesSummer B Dewdney, Nora T Kizer, Abegail A Andaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology StudyLarry J Copeland, Mark F Brady, Robert A Burger, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
The Lancet. Gastroenterology & Hepatology|August 4, 2023
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trialRobert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Gynecologic Oncology|October 13, 2018
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group studyBradley J Monk, James T Kauderer, Katherine M Moxley, et al.
Gynecologic Oncology|September 14, 2025
Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.SNancy Zhou, Anna L Beavis, Lilie L Lin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 17, 2012
Uterine serous carcinoma: increased familial risk for lynch-associated malignanciesSummer B Dewdney, Nora T Kizer, Abegail A Andaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology StudyLarry J Copeland, Mark F Brady, Robert A Burger, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
The Lancet. Gastroenterology & Hepatology|August 4, 2023
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trialRobert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.
Pageof 2